Dr. Assikis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
775 Poplar Rd
Ste 310
Newnan, GA 30265Phone+1 770-251-2590Fax+1 770-251-1490- Is this information wrong?
Summary
- Dr. Vasileios Assikis is an oncologist in Newnan, GA and is affiliated with multiple hospitals in the area, including Piedmont Hospital and Piedmont Newnan Hospital. He received his medical degree from Aristotle University of Thessaloniki School of Medicine and has been in practice 26 years. He specializes in breast cancer, genitourinary oncology, and hematologic oncology and is experienced in hematologic oncology, breast cancer, prostate cancer, gynecologic oncology, and urologic oncology.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2000 - 2003
Cook County Health and Hospitals SystemResidency, Internal Medicine, 1996 - 2000
Aristotle University of Thessaloniki School of MedicineClass of 1991
Certifications & Licensure
GA State Medical License 2003 - 2025
TX State Medical License 2000 - 2004
IL State Medical License 1996 - 2002- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Atlanta Magazine: Top Doctors Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2012
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer Start of enrollment: 2019 Jan 01
Publications & Presentations
PubMed
- 58 citationsTRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.Samuel R. Denmeade, Hao Wang, Neeraj Agarwal, David Smith, Michael T. Schweizer, Mark N. Stein, Vasileios J. Assikis, Przemyslaw Twardowski, Thomas W. Flaig, Russell Z...> ;Journal of Clinical Oncology. 2021 Feb 22
- Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant...Armstrong AJ, Häggman M, Stadler WM, Gingrich JR, Assikis V, Polikoff J, Damber JE, Belkoff L, Nordle Ö, Forsberg G, Carducci MA, Pili R> ;Clin. Cancer Res.. 2013-12-15
- 159 citationsPhase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerRoberto Pili, Michael Häggman, Walter M. Stadler, Jeffrey R. Gingrich, Vasileios J. Assikis, Anders Björk, Orjan Nordle, Göran Forsberg, Michael A. Carducci, Andrew J....> ;Journal of Clinical Oncology. 2011 Oct 20
- Join now to see all
Hospital Affiliations
Piedmont Atlanta HospitalAtlanta, Georgia- Piedmont Newnan HospitalNewnan, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
